CNXU logo

CNXU Conexeu Sciences Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$2.06
-0.14 (-6.56%)

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

Market Cap: $63.66Mwww.conexeu.com

Price

No data yet.

Social Signal Score

44
5d
50
1 mentions
—
30d
50
2 mentions
—
60d
38
4 mentions
—
90d
40
5 mentions
—
news: 5

Analyst Ratings

Avg price target$20+868.5%
Low $20Median $20High $20
Current Consensus

Company Profile

CEO
Miles Harrison
Sector
Healthcare
Industry
Biotechnology
Employees
4
Beta
0.51
Country
US
www.conexeu.com